Carregant...
Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy
U.S. SEER (Surveillance Epidemiology and End Results) data for age-adjusted mortality rates for all cancers combined for all races show only a modest overall 13% decline over the past 35 years. Moreover, the greatest contributor to cancer mortality is treatment-resistant metastatic disease. The acce...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3691519/ https://ncbi.nlm.nih.gov/pubmed/23805101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2013.00068 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|